At LogiPharma USA 2026, BMS’s Kevin Cook explains why CMO partnerships must move beyond transactions toward shared goals and KPIs.
Commentary|Podcasts|January 14, 2026
Pharma Pulse: Precision Cancer Care
Author(s)Nicholas Saraceno, Senior Editor
In today’s Pharma Pulse, Novartis expands its US radioligand footprint, and 15,000 New York City nurses go on strike.
Advertisement
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines.
- First, Novartis is scaling up treatment. The pharma giant has announced plans to build its
fourth US-based radioligand therapy facility . This move is a massive bet on precision oncology. The facility is expected to be completed by 2029, and is anticipated to bolster the Big Pharma company’s specialized supply chain and manufacturing services across its vast RLT production facility network. - But the industry’s progress faces a major hurdle on the front lines: labor. In New York City,
nearly 15,000 nurses have gone on strike at major medical centers. The walkout underscores a breaking point in healthcare, with nurses citing staffing ratios and pay. It’s a stark reminder that even the best medicines can’t reach patients if the delivery system is fractured.
That’s it for this episode of Pharma Pulse. For more insights on trends transforming pharmaceutical access and care delivery, visit
Thanks for listening—until next time, stay well and stay informed.
You can catch Pharma Pulse directly on
Advertisement
Related to this article
In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.
In this week's Pharma Pulse, the EU Council adopts the "pharma package," Commerce details 0% tariffs for certain drugs and Sharp expands autoinjector assembly capacity.
In this week's Pharma Pulse, Vicapsys merges with Stateline, Veritiv targets GLP-1 shipping, Section 232 tariffs widen and HRSA's 340B rebate pilot deadline arrives.
Zoomlogi’s Henry Ames says exception handling still hinges on experienced staff, and AI agents could gather and document details for their judgment calls.
In this week's Pharma Pulse, DHL adds six dedicated cold chain air corridors linking Europe and North America to Asia, Walmart rolls out a $0 prescription tier and rare disease Center of Excellence for its US workforce and FDA launches its Rare Disease Framework Initiative.
Cencora's Matt Sample explains how AI compares forecasts with ordering patterns to flag pharma demand shifts early, with 10% forecasting gains.
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains why validation, change management and stakeholder alignment now drive automation projects.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Inside Cencora's Approach to AI-Driven Demand Sensing
2
Pharma Pulse: DHL's New Cold Chain Corridors and Walmart's $0 Prescription Tier
3
BMS’s Kevin Cook on Moving CMO Partnerships Beyond Transactions
4
What AI Changes, and Doesn’t, in Exception Handling
5